- Report
- March 2026
- 150 Pages
Canada
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 150 Pages
China
From €4377EUR$4,850USD£3,792GBP
- Report
- May 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 83 Pages
Japan
From €2572EUR$2,850USD£2,229GBP
- Report
- March 2026
- 85 Pages
Thailand
From €2572EUR$2,850USD£2,229GBP
- Report
- March 2026
- 83 Pages
South Korea
From €2572EUR$2,850USD£2,229GBP
- Report
- March 2026
- 80 Pages
China
From €2572EUR$2,850USD£2,229GBP
- Report
- March 2026
- 85 Pages
India
From €2572EUR$2,850USD£2,229GBP
- Report
- March 2026
- 83 Pages
Argentina
From €2572EUR$2,850USD£2,229GBP
- Report
- March 2026
- 140 Pages
Canada
From €2572EUR$2,850USD£2,229GBP
- Report
- March 2026
- 82 Pages
Brazil
From €2572EUR$2,850USD£2,229GBP
- Report
- March 2026
- 83 Pages
France
From €2572EUR$2,850USD£2,229GBP
- Report
- February 2026
- 82 Pages
Germany
From €2572EUR$2,850USD£2,229GBP
- Report
- July 2024
- 114 Pages
Global
From €3564EUR$3,950USD£3,089GBP
- Report
- April 2024
- 114 Pages
Global
From €3564EUR$3,950USD£3,089GBP
- Report
- January 2024
- 146 Pages
Global
From €3835EUR$4,250USD£3,323GBP
- Report
- January 2024
- 140 Pages
Global
From €3835EUR$4,250USD£3,323GBP
- Report
- December 2023
- 145 Pages
Global
From €4016EUR$4,450USD£3,480GBP
- Report
- November 2023
- 140 Pages
Global
From €4016EUR$4,450USD£3,480GBP
- Report
- February 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more